Hidaya Mansouri

Dr. Hidaya Mansouri

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 July 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HMHidaya Mansouri
Hidaya Mansouri
LMLeah F. Mnango
Leah F. Mnango
EMErick P. Magorosa
Erick P. Magorosa
ESElingarami Sauli
Elingarami Sauli
Emmanuel MpolyaEmmanuel Mpolya
Emmanuel Mpolya
This study associated Ki-67, p53, and BCL-2 markers with clinical histopathological (CH) features using currently available limited data on these markers in Tanzania. Retrospective chart review study was conducted among females with confirmed breast cancer (BC) at Muhimbili National Hospital in Tanzania between 2016 and 2017. Inclusion criteria were met by 76 patients with a mean age of 51.32 ± 14.28 years. Of these, 86.4% were stage III and IV, whereas 83.5% cases had grade 2 and grade 3. Upon immunostaining, 85.5% and 57.9% were Ki-67 and BCL-2 positive respectively. Log-linear analysis showed no statistically significant association among biomarkers expression and CH features. However, multinomial linear regression showed higher possibility for association between high expression of Ki-67, low expression of p53 and high expression of BCL-2 with age, grade, stage and tumor (T) stage. BCL-2 was positively correlated with Ki-67 expression contrary to p53, which was negatively correlated with BCL-2. Conclusively, there is evidence of correlation between the studied markers with CH features. However, studies with larger sample sizes will likely reveal significant associations that will validate the role of these markers as tools for evaluating treatment response in individualized therapeutic schemes in Tanzania.

Verified
Journal Article
Open access
PDF file
HMHidaya Mansouri
Hidaya Mansouri
AIAhmed Irchad
Ahmed Irchad
CRClarence Rubaka
Clarence Rubaka
LKLydia Kisula
Lydia Kisula
AHAbdou Azali Hamza
Abdou Azali Hamza
ESElingarami Sauli
Elingarami Sauli
Breast cancer remains a major global health challenge despite advances in chemotherapy, endocrine therapy, targeted therapy, and radiotherapy, which are frequently constrained by therapeutic resistance, cumulative toxicity, and high costs. Accumulating preclinical and translational evidence demonstrates that plant-derived natural compounds can synergistically enhance the efficacy of conventional treatments, improve tumor response, and potentially reduce adverse effects. This review critically synthesizes in vitro, in vivo, and emerging clinical studies from 2015 to 2025, focusing on key phytochemicals, including curcumin, epigallocatechin-3-gallate, resveratrol, kaempferol, genistein, and other bioactive molecules as stand alone agents and as mechanistically validated adjuvants to chemotherapy, hormonal therapy, and radiotherapy. These compounds exert complementary actions, including the inhibition of PI3K/Akt/mTOR and NF-κB signaling, induction of apoptosis and cell-cycle arrest, suppression of epithelial–mesenchymal transition, and modulation of drug resistance pathways. Preclinical studies consistently show that combination strategies enhance tumor inhibition and may permit cytotoxic dose reduction, mitigating systemic and cardiotoxic effects. Nanocarrier-based delivery systems further optimize solubility, bioavailability, and tumor targeting. Despite robust preclinical evidence, clinical translation is limited by variability in raw materials, lack of standardization, regulatory barriers, and scarce large-scale trials. This review emphasizes both the therapeutic promise and translational challenges of integrating natural compounds as synergistic adjuvants in evidence-based breast cancer therapy.

1 July 2020 in Multidisciplinary Cancer Investigation
Verified
Journal Article
Closed access
PDF file
HMHidaya Mansouri
Hidaya Mansouri
AMAmos R. Mwakigonja
Amos R. Mwakigonja
FRFaith A. Rodgers
Faith A. Rodgers
EMEmmanuel A. Mpolya
Emmanuel A. Mpolya
SESauli Elingarami
Sauli Elingarami
Tanzania continues to enjoy stability and growth in different sectors similar to other countries; however, some challenges persist in the health sector, especially in the area of cancer care. The current study aimed at reviewing social economic status (SES), as well as factors contributing to the increased burden of breast ...

29 April 2026 in Metabolites
Verified
Journal Article
Open access
PDF file
AIAhmed Irchad
Ahmed Irchad
Charaf Ed-dine KASSIMICharaf Ed-dine KASSIMI
Charaf Ed-dine KASSIMI
ISIbrahim Salmata
Ibrahim Salmata
HMHidaya Mansouri
Hidaya Mansouri
YTYssoufa Thabiti
Yssoufa Thabiti
LHLahcen Hssaini
Lahcen Hssaini
Background/Objectives: Coffea canephora (robusta) and Coffea liberica var. dewevrei (excelsa) cultivated in the Comoros islands represent understudied coffee varieties grown in a unique volcanic terroir. Despite their agricultural significance and potential bioactive value, no comprehensive biochemical or nutritional characterization of these Comorian coffees had previously been conducted. This study therefore aimed to provide the first integrated biochemical and nutritional characterization of both varieties and to evaluate the influence of the islands’ specific edaphoclimatic conditions on their chemical composition. Methods: An integrated analytical approach was employed, combining UV-Vis spectrophotometry, HPLC, ionomics, and FTIR-ATR spectroscopy to quantify polyphenols, flavonoids, caffeine, soluble sugars, antioxidant activity, mineral profiles, and macromolecular composition of green coffee beans from both species. Results: Robusta exhibited significantly higher levels of total polyphenols (121.79 ± 2.73 mg GAE/g), total flavonoids (29.43 ± 2.20 mg QE/g), caffeine (1.52% w/w), total soluble sugars (60.47 ± 3.37 mg GE/g), and antioxidant activity (64.97 ± 6.25 mM Trolox eq/g). Conversely, excelsa demonstrated a distinct mineral profile, with significantly higher concentrations of magnesium, calcium, sodium, zinc, and copper. FTIR spectroscopy confirmed distinct vibrational fingerprints between the two species, particularly in lipid and carbohydrate signatures. Conclusions: These findings position Comorian robusta as a potent source of antioxidants and stimulants, while excelsa offers a nutritionally balanced profile with nutraceutical potential, providing a scientific basis for valorizing both varieties as high-value niche products and contributing to the preservation of coffee agro-biodiversity.